¹Ù·½QQ
¹Ù·½Î¢ÐÅ
ÊÖ»ú°æ
ÄúµÄλÖãºÊ×Ò³ >˶ʿÉúµ¼Ê¦>ÖÐÒ©Ò©Àí·½Ïò>ÏêϸÄÚÈÝ

ÖÐÒ©Ò©Àí·½Ïò

ÁõÈØ

9c5ed0f2efd244b19e8d003088a63666.jpg

Ò»¡¢¸öÈ˼ò½é

ÁõÈØ£¬ÖÐҩѧ²©Ê¿¡¢½ÌÊÚ¡¢Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡¢Ä¿Ç°ÈÎÖ°ÓÚҩѧԺÖÐÒ©Ò©Àíϵ¸±Ö÷ÈΣ»Ä¿Ç°ÈÎÖ°ÓÚËÄ´¨Ê¡Ò©Àíѧ»á¸±ÃØÊ鳤£»Ä¿Ç°Ö÷Òª´ÓÊÂÖÐÒ©¿¹ÒÖÓô×÷Óü°»úÖÆÑо¿£»»ñµÃ»ù½ð×ÊÖú×÷Ϊ¿ÎÌ⸺ÔðÈËÏȺóÉêÇë»ñµÃ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄêÏîÄ¿¡¢ËÄ´¨Ê¡¿Æ¼¼ÌüÓ¦Óûù´¡ÏîÄ¿¡¢mg老虎机游戏ÐÓÁÖѧÕßÏîÄ¿£¬²ÎÑйú¼Ò¼¶¼°²¿Ê¡¼¶¿ÎÌâ¶àÏ½üÄêÔÚ¹úÄÚÍâѧÊõÆÚ¿¯·¢±íѧÊõÎÄÕ¶þÊ®Óàƪ¡¢ÉêÇë»ñµÃÊÚȨ·¢Ã÷רÀûÒ»Ïî¡¢»ñµÃ»ªÏÄҽѧ¿Æ¼¼ÈýµÈ½±¡¢»ñµÃËÄ´¨Ê¡¿Æѧ¼¼Êõ½ø²½¶þµÈ½±¡¢¶à´Î»ñµÃÓÅÐã½ÌÖ°Ô±¹¤¡¢ÓÅÐã¹²²úµ³Ô±ÈÙÓþ³ÆºÅ£»±»ÆÀѡΪµÚ¶þ½ìmg老虎机游戏¡°½ÌѧÐÂÐ㡱¡¢mg老虎机游戏µÚ¶þ½ì±¾¿Æ¿ÎÌýÌѧÖÊÁ¿½±ÌصȽ±¡£


¶þ¡¢´ú±íÐԳɹû

1. Dan Li , Bo Li , Yixin RuiHongxiao XieXiumeng Zhang , Rong Liu* , Nan Zeng* Piperazine ferulate attenuates gentamicin-induced acute kidney injury via the NF-¦ÊB/NLRP3 pathway£¬Phytomedicine. 20222 26;99:154021

2. Yixin Rui , Sheng Li , Fei Luan , Dan Li , Rong Liu , Nan Zeng  2Several Alkaloids in Chinese Herbal Medicine Exert Protection in Acute Kidney Injury: Focus on Mechanism and Target Analysis Oxid Med Cell Longev 2022 05 13;2022 

3. Zeng J,Ji Y,Luan F,Hu J,Rui Y,Liu Y,Rao Z,Liu R,Zeng N. Xiaoyaosan ethyl acetate fraction alleviates depression-like behaviors in CUMS mice by promoting hippocampal neurogenesis via modulating the IGF-1R¦Â/PI3K/Akt signaling pathway[J].Journalof Ethnopharmacology,2022,188: 115055.

4. QINGXIN YANG, QI LIU, HONGJUN LV, FENG WANG, RONG LIU* and NAN ZENG*.Effect of pulegone on the NLPR3 inflammasome during inflammatory activation of THP-1 cells.Experimental and Therapeutic Medicine,2019,10.3892

5. Shi B,Luo J,Fang Y,Liu X,Rao Z,Liu R,Zeng N*.Xiaoyao Pills Prevent Lipopolysaccharide-I-nduced Depression by Inhibiting Inflammation and Protecting Nerves[J].Front Pharmacol,2019,10:1324.

6. ʯ²©Óî,Ò¶ÏþÁÖ,ÂÞ½Ü,ÁõС²¨,ÅíÏ£,ÁõÈØ,ÔøÄÏ*.åÐңɢ¶ÔÖ¬¶àÌÇÓÕµ¼ÒÖÓôÑùÐÐΪµÄÓ°Ïì[J]. ÖгÉÒ©,2019,41(04):760-766.

7. ÂÞ½Ü,ÁõС²¨,ÂÀºì¾ý,ÑîÇåöÎ,ÂæÑàÇÕ,ÔøÄÏ*,ÁõÈØ*.åÐңɢ¶ÔÒÖÓô´óÊóµÄÐÐΪѧ¼°¿¹Ñõ»¯×÷ÓõÄÓ°Ïì[J]. ÖгÉÒ©,2019,41(12):2869-2875.

8. ÂÞ½Ü,·½Ñó,Ôø¾ÅÉ®,¼ÍÑÅ·Æ,ÁõÈØ*,ÔøÄÏ*.»ùÓÚPI3K-AKT-Nrf2/BDNFͨ·Ñо¿åÐңɢ¿¹ÒÖÓô×÷ÓõĻúÖÆ[J]. ÖÐÒ©Ò©ÀíÓëÁÙ´²,2019,35(06):2-6. 

ÖÕÉó£ºÒ©Ñ§Ôº×ܹÜÀíÕ˺Å